Vico Therapeutics is a pioneering brand dedicated to providing innovative RNA modulating therapeutics for patients suffering from rare CNS disorders. Guided by science and a commitment to patients, our mission is simple: to bring groundbreaking RNA modulating therapies to individuals with genetic neurological diseases. Our vision is to establish ourselves as a respected leader in developing antisense oligonucleotide RNA modulators for genetic neurological disorders.

We strive to foster positive and collaborative relationships with patients, physicians, partners, community members, and our fellow employees. At Vico Therapeutics, our core values (TRAITS) shape our culture and drive our performance. We believe that teamwork is crucial for success, and we prioritize mutual respect and accountability within our teams.

Our integrity and transparency build trust among all stakeholders, and ultimately, we exist to serve patients and communities. Led by a talented management team, including our Chief Executive Officer Micah Mackison and Chief Scientific Officer Nicole Datson, PhD, Vico Therapeutics is supported by a dedicated Board of Directors and renowned investors in the biotech industry. Discover the future of RNA modulating therapy with Vico Therapeutics